MedPath

A comparative study of efficacy of Dhurdhurpatradi Taila Shiroabhyanga with Kantakari Taila Shiroabhyanga in the management of Dandruff

Phase 2/3
Not yet recruiting
Conditions
Seborrheic dermatitis. Ayurveda Condition: DARUNAKAH,
Registration Number
CTRI/2025/04/084281
Lead Sponsor
Kalyani Jagannath Bhelke
Brief Summary

Study will be intervened by the treatment of Dhurdhurpatradi Taila and Kantakari Taila Shiroabhyanga to Group A and Group B respectively. The efficacy of therapy will be assessed on the basis of subjective and objective criteria for stastical analysis. According to severity of symptoms sub gradation will be done and appropriate scoring will be designed. The intensity of each system will be calculated before treatment and after treatment and after follow up. The result of treatment will be assessed on the basis of clinical sign and symptoms by adopting suitable grading and scoring system.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
74
Inclusion Criteria

Patient having sign and symptoms of Darunak Patient will be selected irrespective of sex , age, religion, occupation,food habits.

Exclusion Criteria
  • Patients suffering from severe scalp infection like psoriasis, eczema, urticarial rashes.
  • Patient currently or recently using other tropical treatment for Dandruff Patients with known allergies or sensitivities to the ingredients in the study oils.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in symptoms of Kandu ,twak sputan,rukshta7 days
Secondary Outcome Measures
NameTimeMethod
Decrease in symptoms of Keshchyuti,Twak sputan,kandu ,rukshta15days

Trial Locations

Locations (1)

Shri Eknath Ayurved Rugnalaya

🇮🇳

Ahmadnagar, MAHARASHTRA, India

Shri Eknath Ayurved Rugnalaya
🇮🇳Ahmadnagar, MAHARASHTRA, India
Dr Kalyani Jagannath Bhelke
Principal investigator
7875610080
kalyanibhelke221@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.